PBS Biotech
Camarillo, US · Delaware corporation · 1 known investors
Find your way into PBS Biotech
180 people in our graph share verified history with the PBS Biotech team — schools, employers, funds. One of them is your warm intro.
Luke Evninunlockedknows Brian Lee · together at University of California, San Francisco (overlapped)
×2knows the team · via University of Wisconsin-Madison
×7knows the team · via Amgen
×2knows the team · via Michigan State University
PBS Biotech develops Vertical-Wheel bioreactors and related accessories for scalable manufacturing of cell therapies, including allogeneic therapies derived from induced pluripotent stem cells, mesenchymal stem cells, and CAR-T or NK cells. It serves cell therapy developers from R&D through clinical trials and commercialization, offering products, consulting packages, and process scale-up support.
Founders & leadership
BL
Brian LeeinFounder & Chief Technology OfficerBrian Lee is an executive officer and director at PBS Biotech with over 23 years of experience in biopharmaceutical R&D and biomanufacturing, including work on bioprocess development, scale-up, and technology transfer across cell culture, fermentation, and regenerative medicine platforms. He holds patents in biotech and biomanufacturing devices, has published in peer-reviewed journals, and serves on advisory boards for academic bioprocessing programs.
MC
Matt CroughanExecutive
NB
Nelson BermudezinChief Operating Officer, EVP2020–2025
TM
Terrell MathewsinChief Commercial Officer (CCO)
BP
Bryan PoltiloveNamed on SEC filing
JL
Jung LimNamed on SEC filing
Board
XL
Xiaoshen LiaoBoard director
DF
DF
Dennis FentonBoard director
LF
Leland FosterBoard director
Investors · 1
Reported raises · per SEC filings
Form D private placements$43.2M disclosed across 2 of 3 rounds · 2021–2024
▶$8.5MraisedSep 2024 · 3 investors · BiotechnologyRule 506(b)
▶$8.5MraisedSep 2024 · 3 investors · Biotechnology
Rule 506(b)Officers, directors & promoters on the filing
- Xiaoshen LiaoDirector
- Brian LeeExecutive Officer, Director
- Daniel FriedmanDirector
- Matt CroughanExecutive Officer
- Nelson BermudezExecutive Officer
- Terrell MathewsExecutive Officer
- Dennis FentonDirector
- Leland FosterDirector
- Offering amount
- $17M
- Amount sold
- $8.5M
- First sale
- Sep 2024
- Incorporated
- Corporation, Delaware
- Federal exemptions
- 06b
▶$34.7MraisedJan 2023 · 3 investors · BiotechnologyRule 506(b)
▶$34.7MraisedJan 2023 · 3 investors · Biotechnology
Rule 506(b)Officers, directors & promoters on the filing
- Bryan PoltiloveDirector
- Dennis FentonDirector
- Leland fosterDirector
- Jung LimDirector
- Brian LeeExecutive Officer, Director
- Xiaoshen (Jerry) LiaoDirector
- Offering amount
- $34.7M
- Amount sold
- $34.7M
- First sale
- Dec 2022
- Incorporated
- Corporation, Delaware
- Federal exemptions
- 06b
Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.
In the news
Frequently asked questions
- What does PBS Biotech do?
- PBS Biotech develops Vertical-Wheel bioreactors and related accessories for scalable manufacturing of cell therapies, including allogeneic therapies derived from induced pluripotent stem cells, mesenchymal stem cells, and CAR-T or NK cells. It serves cell therapy developers from R&D through clinical trials and commercialization, offering products, consulting packages, and process scale-up support.
- Who founded PBS Biotech?
- PBS Biotech was founded by Brian Lee.
- Who are PBS Biotech's investors?
- PBS Biotech's investors include Avego BioScience Capital.
- How much funding has PBS Biotech raised?
- PBS Biotech has disclosed $43.2M raised across 2 of its 3 known rounds.
- Where is PBS Biotech headquartered?
- PBS Biotech is headquartered in Camarillo, US.